A male-specific mechanism of meningeal nociceptor sensitization promoting migraine headache
Cephalalgia · 2024
DOI: 10.1177/03331024241281493 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cephalalgia, 2024. Verfasst von Caroline M Kopruszinski und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Arizona College of Medicine, Tucson, AZ, USA. Hauptthemen laut MEDLINE: Migraine Disorders, Mice, Inbred C57BL, Orexin Receptors, Trigeminal Ganglion. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS, U.S. Department of Defense, National Institutes of Health.
Abstract (Originalsprache)
Background
We wished to explore possible sexual dimorphism in mechanisms sensitizing or activating meningeal nociceptors that can promote the headache phase of migraine.
Methods
Male and female C57BL6J mice received either supradural orexin B and an inflammatory mediator cocktail (IM) with migraine-like pain behaviors and photophobia recorded. Expression of orexin 2 receptor (OX2R) in trigeminal ganglion (TG) and phosphorylated extracellular signal-regulated kinases (ERK) levels in trigeminal nucleus caudalis (TNC) were evaluated. Orexin B-induced excitability of TG cells was assessed with patch-clamp electrophysiology. Intranasal delivery of CRISPR/Cas9 plasmids was used to edit the expression of OX2R in the TG.
Results
Supradural orexin B induced migraine-like pain behaviors, photophobia and increased TNC ERK phosphorylation exclusively in males. Blockade of orexin signaling with supradural suvorexant, a dual orexin receptor antagonist, prevented, but did not reverse, migraine-like pain in males induced by supradural IM cocktail. OX2R expression was higher in male TG and orexin B increased TG neuron excitability in males. Intranasal OX2R CRISPR/Cas9 reduced TG receptor expression and orexin B-induced TNC ERK phosphorylation and prevented migraine-like pain induced by supradural orexin B in males.
Conclusions
Our studies reveal a male-specific mechanism of TG nociceptor sensitization and migraine-like pain behavior mediated by orexin B/OX2R signaling. Sexually dimorphic mechanisms of trigeminal nociceptor sensitization and activation offer opportunities to improve patient outcomes by considering patient sex and may influence clinical trial design and interpretation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University of Arizona College of Medicine, Tucson, AZ, USA.
- Department of Anesthesiology, University of Arizona College of Medicine, Tucson, AZ, USA.
- Pharmacology and Physiology, Saint Louis University, St. Louis, MO, USA.
- Department of Neurology, Mayo Clinic, Phoenix, AZ, USA.
- Atria Academy of Science and Medicine, New York, NY, USA.
ORCID-Profile: Caroline M Kopruszinski, Frank Porreca
Förderung
- NINDS NIH HHS
- U.S. Department of Defense
- National Institutes of Health
Zitieren
APA
Kopruszinski, C. M., Lee, G., Martin, L. K., Barber, K. R., Moutal, A., Dodick, D. W., Navratilova, E., & Porreca, F. (2024). A male-specific mechanism of meningeal nociceptor sensitization promoting migraine headache. Cephalalgia. https://doi.org/10.1177/03331024241281493
Vancouver
Kopruszinski CM, Lee G, Martin LK, Barber KR, Moutal A, Dodick DW, et al. A male-specific mechanism of meningeal nociceptor sensitization promoting migraine headache. Cephalalgia. 2024. doi:10.1177/03331024241281493
BibTeX
@article{Kopruszinski2024,
author = {Kopruszinski, Caroline M and Lee, Grace and Martin, Laurent K and Barber, Kara R and Moutal, Aubin and Dodick, David W and Navratilova, Edita and Porreca, Frank},
title = {A male-specific mechanism of meningeal nociceptor sensitization promoting migraine headache},
journal = {Cephalalgia},
year = {2024},
doi = {10.1177/03331024241281493}
}
EUVIMED